Table 1.
Comorbidities Diagnoses at Baseline and Follow-up among Patients with Documented Sexual Assault (SA) and Matched Non-SA Patients.
| Comorbidity | Baseline (N = 5,400) | Follow-Up (N = 5,400) | P-value comparing baseline vs. follow-up among |
|||||
|---|---|---|---|---|---|---|---|---|
|
| ||||||||
| % of SA patients (N = 1,350) |
% of non-SA patients (N = 4,050) |
P-value | % of SA patients (N = 1,350) |
% of non-SA patients (N = 4,050) |
P-value | SA patients (N = 1,350) |
non-SA patients (N = 4,050) |
|
| Psychiatric Disorders | ||||||||
| Anxiety Disorder | 35.0 | 8.4 | <0.001 | 46.4 | 8.0 | <0.001 | <0.001 | 0.49 |
| Depressive Disorder | 37.2 | 8.4 | <0.001 | 47.8 | 8.3 | <0.001 | <0.001 | 0.97 |
| Eating Disorder | 1.9 | 0.4 | <0.001 | 2.3 | 0.3 | <0.001 | 0.42 | 0.43 |
| Bipolar Disorder | 11.3 | 1.5 | <0.001 | 14.2 | 1.5 | <0.001 | 0.02 | 1.00 |
| Posttraumatic Stress Disorder | 11.0 | 0.8 | <0.001 | 24.4 | 0.5 | <0.001 | <0.001 | 0.10 |
| Psychotic Disorders | 5.3 | 1.4 | <0.001 | 6.6 | 1.7 | <0.001 | 0.17 | 0.37 |
| Any | 53.7 | 14.5 | <0.001 | 66.8 | 14.4 | <0.001 | <0.001 | 0.90 |
| Substance Use Disorders | ||||||||
| Alcohol Use Disorder | 7.4 | 0.7 | <0.001 | 11.6 | 0.8 | <0.001 | <0.001 | 0.44 |
| Drug Use Disorder | 6.8 | 1.0 | <0.001 | 11.5 | 0.9 | <0.001 | <0.001 | 0.73 |
| Any | 11.7 | 1.5 | <0.001 | 17.9 | 1.5 | <0.001 | <0.001 | 0.85 |
| Stress-Related Somatic Conditions | ||||||||
| Stress | 11.1 | 1.9 | <0.001 | 16.3 | 1.6 | <0.001 | <0.001 | 0.31 |
| Insomnia | 8.5 | 1.8 | <0.001 | 8.3 | 1.6 | <0.001 | 0.84 | 0.50 |
| Palpitations | 2.4 | 1.4 | 0.01 | 3.0 | 0.9 | <0.001 | 0.34 | 0.05 |
| Fatigue | 6.4 | 3.0 | <0.001 | 7.6 | 3.0 | <0.001 | 0.26 | 0.90 |
| Urticaria | 1.4 | 0.8 | 0.07 | 2.2 | 0.9 | <0.001 | 0.11 | 0.90 |
| Any | 25.0 | 8.1 | <0.001 | 30.5 | 7.1 | <0.001 | 0.001 | 0.10 |
| Gastrointestinal Conditions | ||||||||
| Dyspepsia | 1.7 | 0.9 | 0.01 | 1.7 | 0.8 | 0.01 | 1.00 | 0.72 |
| Irritable Bowel Syndrome | 4.2 | 1.4 | <0.001 | 4.4 | 1.4 | <0.001 | 0.77 | 0.92 |
| Peptic Ulcer | 0.2 | 0.1 | 0.44 | 0.4 | 0.1 | 0.001 | 0.16 | 0.65 |
| Any | 5.7 | 2.3 | <0.001 | 5.9 | 2.3 | <0.001 | 0.87 | 1.00 |
| Pain | ||||||||
| Pelvic Pain | 9.3 | 3.2 | <0.001 | 10.6 | 3.4 | <0.001 | 0.27 | 0.62 |
| Abdominal Pain | 16.0 | 8.4 | <0.001 | 18.5 | 8.1 | <0.001 | 0.07 | 0.69 |
| Headache | 12.6 | 5.9 | <0.001 | 14.7 | 6.4 | <0.001 | 0.10 | 0.33 |
| Fibromyalgia | 6.2 | 0.8 | <0.001 | 5.9 | 1.8 | <0.001 | 0.81 | 0.38 |
| Chronic, neck, and back pain | 27.6 | 12.5 | <0.001 | 28.7 | 12.4 | <0.001 | 0.52 | 0.95 |
| Any | 44.2 | 24.1 | <0.001 | 47.0 | 24.2 | <0.001 | 0.15 | 0.94 |
| Genitourinary Conditions | ||||||||
| Incontinence | 1.0 | 0.8 | 0.34 | 1.3 | 0.6 | 0.03 | 0.59 | 0.51 |
| Vulvodynia | 0.2 | 0.2 | 0.56 | 0.3 | 0.1 | 0.02 | 0.71 | 0.16 |
| Pain during intercourse | 1.3 | 0.6 | 0.01 | 2.3 | 0.5 | <0.001 | 0.06 | 0.65 |
| Vaginitis | 0.0 | 0.1 | 0.41 | 0.6 | 0.2 | 0.01 | 0.005 | 0.16 |
| Sexually Transmitted Infection | 1.9 | 0.6 | <0.001 | 2.6 | 0.6 | <0.001 | 0.24 | 0.89 |
| Any | 4.4 | 2.1 | <0.001 | 6.7 | 2.0 | <0.001 | 0.01 | 0.75 |
| Other | ||||||||
| Smoking | 20.6 | 7.9 | <0.001 | 20.7 | 7.7 | <0.001 | 0.97 | 0.76 |
| Obesity (BMI>=30) | 39.4 | 33.8 | <0.001 | 40.1 | 35.2 | 0.004 | 0.72 | 0.23 |
Note. Boldface indicates statistical significance (p<0.001). Patients were matched on year of birth, sex, facility, and continuous enrollment (defined as enrollment gaps of less than 6 months) in the two years surrounding the SA. Baseline = 12 months prior to SA documentation or the same time period among matched non-SA patients. Follow-up = 12 months post SA documentation or the same time period among matched non-SA patients.